Dr Mohd Farooq Shaikh

Associate Professor

Jeffrey Cheah School of Medicine & Health Sciences

Email: farooq.shaikh@monash.edu
Tel: +603 5514 4483
Office: Room 3-2-09

ORCID ID: https://orcid.org/0000-0001-9865-6224

Profile Summary

Dr Mohd. Farooq Shaikh is an Associate Professor in neuropharmacology at Monash Medicine and leader of Neuropharmacology Research Strength. He is an expert neuropharmacologist and interested in both drug discovery and understanding the disease mechanisms of epilepsy and Alzheimer’s  disease. His team at Monash University Malaysia has developed a zebrafish model to study the co-morbidities (secondary condition) of epilepsy. This newly developed model using the zebrafish will not only allow scientists to understand the mechanism of the disease but also help in developing safer drugs. His team is also working on unravelling the molecular mechanisms involved in disease progression, especially the role of inflammatory biomarkers in epilepsy and other brain disorders. Utilizing again zebrafish models, his group is studying dynamics of an important inflammatory biomarker HMGB1, which has a controversial role in many neurological and non-neurological disease conditions. He is also leading multidisciplinary projects such as early detection and prevention of epileptic seizures using machine learning and biomedical engineering. He is also involved in a project that tackles the stigma associated with epilepsy for improving the quality of life of individuals.

He is a recipient of Monash's PVC Award for Excellence in Research (2020 and 2018) and Best Publication Award by Malaysian Society of Neuroscience (MSN) in 2017. He is also recipient of Malaysian Society of Pharmacology & Physiology (MSPP) 2019 Best Young Researcher and 2019 Best Young Teacher (Pharmacology) Awards. He is involved in PhD supervision and publishing papers in high impact journals. He has published over 100 peer-reviewed articles, including book chapters in quality journals.

Dr Farooq completed his PhD in Pharmacology from the Institute of Chemical Technology, University of Mumbai, India, in 2012. During his PhD (2011), he was also selected by the International Brain Research Organization (IBRO) to be part of the prestigious Young Scientist Training Program for his research work in epilepsy. In 2012, he was awarded the IBRO-APRC fellowship to continue his post-doctoral studies at School of Biomedical Sciences, University of Queensland, Australia, where he worked with Dr Karin Borges on epilepsy therapy research.

Qualifications

  • Graduate Certificate in Higher Education (GCHE), Monash University, Malaysia.
  • PhD in Pharmacology, Institute of Chemical Technology, University of Mumbai, India.
  • MPharm in Pharmacology, Rajiv Gandhi University of Health Sciences, India.
  • BPharm, Rajiv Gandhi University of Health Sciences, India.

Professional Experience

July 2021 – Present Associate Professor, Jeffrey Cheah School of Medicine and Health Sciences, Monash University Malaysia

Jan 2018 – July 2021 Senior Lecturer, Jeffrey Cheah School of Medicine and Health Sciences, Monash University Malaysia

2019 – Present Adjunct Senior Research Fellow, Department of Neuroscience, Central Clinical School, Faculty of Medicine Nursing and Health Sciences, Monash University, Australia

2013 – 2017 Lecturer, Jeffrey Cheah School of Medicine and Health Sciences, Monash University Malaysia

2012 IBRO-APRC Fellow, Department of Pharmacology, University of Queensland, Brisbane, Australia

2008 – 2012 PhD Student (Senior Research Fellow, Indian Council of Medical Research-2010–2012), Department of Pharmaceutical Sciences and Technology, Institute of Chemical Technology, University of Mumbai, India

2008 – 2012 PhD Student (Senior Research Fellow, University Grants Commission- MANF, India-2009), Department of Pharmaceutical Sciences and Technology, Institute of Chemical Technology,  University of Mumbai, India

2007 – 2008 Research Assistant, Department of Pharmaceutical Sciences and Technology, Institute of Chemical Technology, University of Mumbai, India

Leadership and Coordination

  • Leading Neuropharmacology Research Cluster at Jeffrey Cheah School of Medicine and Health Sciences, Monash University Malaysia since 2014.
  • Regional Representative for Young Epilepsy Section-International League Against Epilepsy (YES-ILAE).
  • Member International League Against Epilepsy (ILAE)- TaskForce for Research & Advocacy
  • Deputy Chair, Monash University Malaysia- Animal Ethics Committee (MUM-AEC).
  • Ex-co Member of Malaysian Epilepsy Society
  • Ex-co Member of Malaysian Epilepsy Council
  • Member of Malaysian Society of Pharmacology & Physiology (MSPP).
  • Coordinator- Pharmacology for MBBS program at Jeffrey Cheah School of Medicine and Health Sciences, Monash University Malaysia.
  • Coordinator for zone ‘M’ for “Malaysian Brain Bee Challenge” a nationwide University-Community project to find Malaysian Brain Bee who will represent Malaysia in International Brain Bee Challenge every year.
  • Coordinator for zone ‘M’ for “Malaysian Brain Bee Challenge-Junior” a national level University-Community project for student aged 10-12 years.
  • Organiser for “CURE: Epilepsy Seminar and Research Meeting”, selected to host 2018 Frontiers in Research Seminar Series Program funded by CURE (Citizens United for Research in Epilepsy), USA to represent epilepsy research in University seminars and to educate and inspire the best and brightest minds to consider entering the field.

Research Interests

Epilepsy, Post-Traumatic Epilepsy, Gut-Brain-Axis in Epilepsy associated comorbidities, Animal Models, Anticonvulsant Screening, Alzheimer’s disease, Learning & Memory

Teaching Commitments

Discipline Coordinator - Pharmacology
Units taught: MED 1100/1200 and MED 2100/2200

Recent Publications

In Peer-Reviewed Indexed Journals

2021 (Impact factor: 81.226) as of August 19, 2021

Enes Akyüz, Betül Köklü, Cansu Ozenen, Alina Arulsamy and Mohd. Farooq Shaikh. Elucidating the Potential Side Effects of Current Anti-Seizure Drugs for Epilepsy. Curr Neuropharmacol. 2021 (Q1, IF. 7.363, top 10%). Accepted

Yam Nath Paudel, Shafi Ullah Khan, Iekhsan Othman and Mohd. Farooq Shaikh. Naturally Occurring HMGB1 Inhibitor, Glycyrrhizin, Modulates Chronic Seizures-Induced Memory Dysfunction In Zebrafish Model. ACS Chemical Neuroscience. 2021 (Q1, IF. 4.418) Accepted.

Brandon Kar Meng Choo, Uday Praful Kundap, Siti Munirah Mohd Faudzi, Faridah Abas, Mohd. Farooq Shaikh, Éric Samarut. Identification of curcumin analogues with anti-seizure potential in vivo using chemical and genetic zebrafish larva seizure models. Biomedicine & Pharmacotherapy, 142, 2021, 112035, https://doi.org/10.1016/j.biopha.2021.112035 (Q1, IF: 6.529, top 10%)

Retinasamy, T. and Shaikh, M. F. (2021) “Aducanumab for Alzheimer’s disease: An update”, Neuroscience Research Notes, 4(2), pp. 17–20. doi: 10.31117/neuroscirn.v4i2.81.

Chung, Y.-S.; Ahmed, P.K.; Othman, I.; Shaikh, M.F. Orthosiphon stamineus Proteins Alleviate Hydrogen Peroxide Stress in SH-SY5Y Cells. Life 2021, 11, 585. https://doi.org/10.3390/life11060585 (Q1, IF. 3.817).

Choo BKM, Shaikh MF. Mechanism of Curcuma longa and Its Neuroactive Components for the Management of Epileptic Seizures: A Systematic Review. Curr Neuropharmacol. 2021 May 17. doi: 10.2174/1570159X19666210517120413. Epub ahead of print. PMID: 33998991. (Q1, IF. 7.363, top 10%). Accepted

Akyüz E, Üner AK, Köklü B, Arulsamy A, Shaikh MF. Cardiorespiratory findings in epilepsy: A recent review on outcomes and pathophysiology. J Neurosci Res. 2021;00:1–15. https://doi.org/10.1002/jnr.24861 (Q1, IF. 4.164)

Usman A, Mustafa N, Iqbal SP, Hasan MZ, Shaikh MF, Dujaili JA, Gan SH. Mapping the role of pH-adjusted potassium in diabetic ketoacidosis: Hypokalemia and the patient outcomes. Int J Clin Pract. 2021 Aug;75(8):e14315. doi: 10.1111/ijcp.14315. Epub 2021 Jun 20. PMID: 33934480. (Q2, IF. 2.503).

Win Ning Chen, Mohd Farooq Shaikh, Saatheeyavaane Bhuvanendran, Abhijit Date, Mohammad Tahir Ansari, Ammu Kutty Radhakrishnan, Iekhsan Othman. Poloxamer 188 (P188), A Potential Polymeric Protective Agent for Central Nervous System Disorders: A Systematic Review. Current Neuropharmacology (Q1, IF. 7.363, top 10%). Accepted.

Ahmad Azam A, Ismail IS, Shaikh MF, Abas F and Shaari K (2021) Multi-Platform Metabolomics Analyses Revealed the Complexity of Serum Metabolites in LPS-Induced Neuroinflammed Rats Treated with Clinacanthus nutans Aqueous Extract. Front. Pharmacol. 12:629561. doi: 10.3389/fphar.2021.629561 (Q1, IF. 5.810).

Akyuz E, Kullu I, Arulsamy A, Shaikh MF. Melatonin as an Antiepileptic Molecule: Therapeutic Implications via Neuroprotective and Inflammatory Mechanisms. ACS Chemical Neuroscience. 2021 Apr;12(8):1281-1292. DOI: 10.1021/acschemneuro.1c00083. (Q1, IF. 4.418)

Akyuz E, Doganyigit Z, Paudel YN, Koklu B, Kaymak E, Villa C, Arulsamy A, Shaikh MF, Devinsky O. Immunoreactivity of Muscarinic Acetylcholine M2 and Serotonin 5-HT2B Receptors, Norepinephrine Transporter and Kir Channels in a Model of Epilepsy. Life. 2021; 11(4):276. https://doi.org/10.3390/life11040276 (Q2, IF. 3.817)

Usman A, Shaikh MF, Dujaili JA, Mustafa N, Gan SH. Re-visiting pH-adjusted potassium to avoid hypokalemic crisis during management of diabetic ketoacidosis: A conceptual framework. Diabetes Metab Syndr. 2021 Mar-Apr;15(2):573-580. doi: 10.1016/j.dsx.2021.03.001 (Q2, Cite Score: 2.6)

Pei Teng Lum, Mahendran Sekar, Siew Hua Gan, Srinivasa Reddy Bonam, Mohd. Farooq Shaikh (2021). Protective Effect of Natural Products against Huntington’s Disease – An Overview of Scientific Evidence and Understanding their Mechanism of Action. ACS Chemical Neuroscience. ACS Chemical Neuroscience 2021 12 (3), 391-418. DOI: 10.1021/acschemneuro.0c00824 (Q1, IF. 4.418)

Paudel YN, Othman I and Shaikh MF (2021) Anti-High Mobility Group Box-1 Monoclonal Antibody Attenuates Seizure-Induced Cognitive Decline by Suppressing Neuroinflammation in an Adult Zebrafish Model. Front. Pharmacol. 11:613009. doi: 10.3389/fphar.2020.613009 (Q1, IF. 5.810).

Zulazmi NA, Arulsamy A, Ali I, Zainal Abidin SA, Othman I, Shaikh MF. The utilization of small non-mammals in traumatic brain injury research: A systematic review. CNS Neurosci Ther. 2021;27:381–402. doi: 10.1111/cns.13590 (Q1, IF. 5.243).

Yam Nath Paudel, Efthalia Angelopoulou, Bhupendra Raj Giri, Christina Piperi, Iekhsan Othman, Mohd. Farooq Shaikh. (2020). A Perspective On The Impact of COVID-19 Pandemic in Basic Science Research and its Future implications. Coronaviruses DOI: 10.2174/2666796701999201223161636. (Accepted)

Angelopoulou, E., Paudel, Y.N., Julian, T., Shaikh M.F., Piperi C. (2020) Pivotal Role of Fyn Kinase in Parkinson’s Disease and Levodopa-Induced Dyskinesia: a Novel Therapeutic Target?. Mol Neurobiol (2020). https://doi.org/10.1007/s12035-020-02201-z (Q1, IF: 5.590)

2020 (Impact Factor: 84.426) as of August 6, 2020

Chung, Y.-S.; Choo, B.K.M.; Ahmed, P.K.; Othman, I.; Shaikh, M.F. Orthosiphon stamineus Proteins Alleviate Pentylenetetrazol-Induced Seizures in Zebrafish. Biomedicines 2020, 8, 191. (Q1, IF: 4.717)

Paudel, Y.N.; Angelopoulou, E.; Piperi, C.; Othman, I.; Shaikh, M.F. HMGB1-Mediated Neuroinflammatory Responses in Brain Injuries: Potential Mechanisms and Therapeutic Opportunities. Int. J. Mol. Sci. 2020, 21, 4609. (Q1, IF: 4.556)

Paudel, Y.N.; Angelopoulou, E.; Piperi, C.; Othman, I.; Shaikh, M.F. Revisiting the Impact of Neurodegenerative Proteins in Epilepsy: Focus on Alpha-Synuclein, Beta-Amyloid, and Tau. Biology 2020, 9, 122. (Q1, IF: 3.796)

Arulsamy A, Shaikh MF. Tumor necrosis factor-alpha, the pathological key of post-traumatic epilepsy: A comprehensive systematic review. ACS Chemical Neuroscience 2020 11 (13), 1900-1908. DOI: 10.1021/acschemneuro.0c00301 (Q1, IF: 4.486)

Kundap, U.P.; Paudel, Y.N.; Shaikh, M.F. Animal Models of Metabolic Epilepsy and Epilepsy Associated Metabolic Dysfunction: A Systematic Review. Pharmaceuticals 2020, 13(6), 106; https://doi.org/10.3390/ph13060106. (Q1, IF: 4.286)

Angelopoulou, E., Paudel, Y. N., Shaikh, M. F., & Piperi, C. (2020). Fractalkine (CX3CL1) signaling and neuroinflammation in Parkinson’s disease: Potential clinical and therapeutic implications. Pharmacological Research, 158, 104930. https://doi.org/10.1016/j.phrs.2020.104930 (Q1, IF: 5.893) Top 10%

Noor AAM, Othman SNN, Lum PT, Mani S, Shaikh MF, Sekar M. Molecules of Interest – Karanjin – A Review. Pharmacognosy Journal,2020,12,4,938-945. DOI:10.5530/pj.2020.12.133(Q3, CiteScore: 0.817)

Chung Y-S, Choo BKM, Ahmed PK, Othman I and Shaikh MF (2020) A Systematic Review of the Protective Actions of Cat’s Whiskers (Misai Kucing) on the Central Nervous System. Front. Pharmacol. 11:692. doi: 10.3389/fphar.2020.00692. (Q1, IF: 4.225)

Akyüz, E.; Doğanyiğit, Z.; Paudel, Y.N.; Kaymak, E.; Yilmaz, S.; Uner, A.; Shaikh, M.F. Increased ACh-Associated Immunoreactivity in Autonomic Centers in PTZ Kindling Model of Epilepsy. Biomedicines 2020, 8, 113. (Q1, IF: 4.717)

Retinasamy, T.; Shaikh, M.F.; Kumari, Y.; Abidin, S.A.Z.; Othman, I. Orthosiphon stamineus Standardized Extract Reverses Streptozotocin-induced Alzheimer’s Disease-Like Condition in a Rat Model. Biomedicines 2020, 8, 104. (Q1, IF: 4.717)

Yam Nath Paudel*, Efthalia Angelopoulou, Christina Piperi, Vadym Gnatkovsky, Iekhsan Othman, Mohd. Farooq Shaikh. (2020) From molecular mechanism to pre-clinical results: Anti-epileptic effects of Fingolimod. Current Neuropharmacology, DOI: 10.2174/1570159X18666200420125017. (In press) (Q1, IF: 4.568)

Angelopoulou, E.; Paudel, Y.N.; Villa, C.; Shaikh, M.F.; Piperi, C. (2020) Lymphocyte-activation Gene 3 (LAG3) Protein as a Possible Therapeutic Target for Parkinson’s Disease: Molecular Mechanisms Connecting Neuroinflammation to α-synuclein Spreading Pathology. Biology 2020, 9, 86; doi:10.3390/biology9040086  (Q1, IF: 3.796)

Paudel, Y.N.; Angelopoulou, E.; Piperi, C:, Othman, I:, Shaikh, M.F.. (2020) Implication of HMGB1 signaling pathways in Amyotrophic lateral sclerosis (ALS): From molecular mechanisms to pre-clinical results. Pharmacological Research, https://doi.org/10.1016/j.phrs.2020.104792. (Q1, IF: 5.893) Top 10%

Shaikh MF, Lee CY, Chen WN and Shaikh FA (2020) The Gut-Brain-Axis on the Manifestation of Depressive Symptoms in Epilepsy: An Evidence-Driven Hypothesis. Front. Pharmacol. 11:465. doi: 10.3389/fphar.2020.00465. (Q1, IF: 4.225)

Shaikh, M. F. and Shaikh, F. A. (2020) “COVID-19 and mental health: Our reactions to its actions”, Neuroscience Research Notes, 3(2), pp. 1-3. doi: 10.31117/neuroscirn.v3i2.46.

Alina Arulsamy; Mohd. Farooq Shaikh. COVID-19: An Update on Research and Development, Encyclopedia, 2020, v1, Available online: https://encyclopedia.pub/item/revision/fd0f3a416455bc2522438b426962f45a

Paudel YN, Kumari Y, Abidin SAZ, Othman I, Shaikh MF. (2020) Pilocarpine Induced Behavioral and Biochemical Alterations in Chronic Seizure-Like Condition in Adult Zebrafish. International Journal of Molecular Sciences. 21(7):2492. (Q1, IF: 4.556)

Angelopoulou, E.; Paudel, Y.N.; Shaikh, M.F.; Piperi, C. (2020) Flotillin: A Promising Biomarker for Alzheimer’s Disease. J. Pers. Med. 10, 20. https://doi.org/10.3390/jpm10020020  (Q1, IF: 4.433)

Yam Nath Paudel, Efthalia Angelopoulou, Christina Piperi, Khurram Aamir, Iekhsan Othman, Mohd. Farooq Shaikh. (2020). Impact of HMGB1, RAGE and TLR4 signaling in the pathogenesis of Alzheimer's disease. Cells, 9(2), 383; https://doi.org/10.3390/cells9020383 (Q1, IF: 4.366)

Paudel, Y. N., Angelopoulou, E., Piperi, C., Shaikh, M. F., & Othman, I. (2020). Emerging Neuroprotective effect of Metformin in Parkinson’s disease: A Molecular crosstalk. Pharmacological Research, 104593. (Q1, IF: 5.893) Top 10%

Paudel, Y. N., Angelopoulou, E., Semple, B., Piperi, C., Othman, I., & Shaikh, M. F. (2020). Potential neuroprotective effect of the HMGB1 inhibitor Glycyrrhizin in neurological disorders. ACS Chemical Neuroscience, 11(4), 485-500. (Q1, IF: 4.486)

2019 (Impact Factor: 75.213)

Efthymiou, Stephanie et al., (SYNaPS Study Group-Farooq Shaikh), "Biallelic mutations in neurofascin cause neurodevelopmental impairment and peripheral demyelination." Brain 142, no. 10 (2019): 2948-2964. (Q1, IF: 11.814). Top 10%

Chelban, Viorica et al., (SYNaPS Study Group-Farooq Shaikh), "PDXK mutations cause polyneuropathy responsive to PLP supplementation." Annals of Neurology (2019). (Q1, IF: 10.244). Top 10%

Salpietro, Vincenzo et al., (SYNaPS Study Group-Farooq Shaikh), "AMPA receptor GluA2 subunit defects are a cause of neurodevelopmental disorders." Nature Communications 10, no. 1 (2019): 1-16.  (Q1, IF: 11.878). Top 10%

Retinasamy T, Shaikh MF, Kumari Y and Othman I (2019) Ethanolic Extract of Orthosiphon stamineus Improves Memory in Scopolamine-Induced Amnesia Model. Front. Pharmacol. 10:1216. doi: 10.3389/fphar.2019.01216 (Q1, IF: 3.831).

Kundap UP, Choo BKM, Kumari Y, Ahmed N, Othman IB and Shaikh MF (2019) Embelin Protects Against Acute Pentylenetetrazole-Induced Seizures and Positively Modulates Cognitive Function in Adult Zebrafish. Front. Pharmacol. 10:1249. doi: 10.3389/fphar.2019.01249. (Q1, IF: 3.831).

Bhuvanendran, S., B, S. N. S., Kumari, Y., Othman, I., Shaikh, M. F., & Hassan, Z. (2019). Embelin improves the Spatial Memory and Hippocampal Long-term potentiation in a Rat Model of chronic cerebral Hypoperfusion. Scientific reports, 9(1), 1-11. (Q1, IF: 4.5). Top 10%

Yam Paudel, Efthalia Angelopoulou, Nigel C. Jones, Terence J. O’Brien, Patrick Kwan, Christina Piperi, Iekhsan Othman, and Mohd. Farooq Shaikh. Tau Related Pathways as a Connecting Link between Epilepsy and Alzheimer’s disease. ACS Chemical Neuroscience DOI: 10.1021/acschemneuro.9b00460. (Q1, IF: 4.21)

Kumari, Y., Choo, B.K., Shaikh, M.F., & Othman, I. (2019). Melatonin receptor agonist Piper betle L. ameliorates dexamethasone‑induced early life stress in adult zebrafish. Experimental and Therapeutic Medicine, 18, 1407-1416. https://doi.org/10.3892/etm.2019.7685. (Q4, IF: 1.448)

Paudel, Y. N., Angelopoulou, E., Piperi, C., Balasubramaniam, V. R., Othman, I., & Shaikh, M. F. (2019). Enlightening the role of high mobility group box 1 (HMGB1) in inflammation: Updates on receptor signalling. European journal of pharmacology, 172487. (Q2, IF: 3.170)

Saatheeyavaane Bhuvanendran, Nur Aziah Hanapi, Nafees Ahmed, Iekhsan Othman, Siti Rafidah Yusof, Mohd. Farooq Shaikh. (2019) Embelin, a potent molecule for Alzheimer’s disease: A proof of concept from BBB permeability, AChE inhibition and molecular docking studies. Frontiers in Pharmacology. (Accepted) (Q1, IF: 3.831).

Kundap, U. P., Paudel, Y. N., Kumari, Y., Othman, I. B., & Shaikh, M. F. (2019). Embelin prevents seizure and associated cognitive impairments in a pentylenetetrazole-induced kindling zebrafish model. Frontiers in Pharmacology, 10, 315. (Q1, IF: 3.831)

Choo, B., Kumari, Y., Hue, S. M. and Shaikh, M. F. (2019) “The treatment of epileptic seizures: the potential of Malaysian medicinal plants”, Neuroscience Research Notes, 1(3), pp. 35-53. doi: 10.31117/neuroscirn.v1i3.27.

Meng, B. C. K., Kundap, U. P., bin Johan Arief, M. F., Kumari, Y., Ling, Y. J., Piau, W. C., I. Othman & Shaikh, M. F. (2019). Effect of newer anti-epileptic drugs (AEDs) on the cognitive status in pentylenetetrazol induced seizures in a zebrafish model. Prog Neuropsychopharmacol Biol Psychiatry. 2019 Mar 4;92:483-493. doi: 10.1016/j.pnpbp.2019.02.014 (Q1, IF: 4.185)

Ayanabha Chakraborti, Mohd. Farooq Shaikh, Annamaria Vezzani, Jafri Malin Abdullah. Experimental models of epilepsy and related comorbidities. Front. Pharmacol. | doi: 10.3389/fphar.2019.00179. (2019) (Q1, IF: 3.831)

Paudel, Y. N., Semple, B. D., Jones, N. C., Othman, I., & Shaikh, M. F. (2019). High mobility group box 1 (HMGB 1) as a novel frontier in epileptogenesis: from pathogenesis to therapeutic approaches. Journal of Neurochemistry. https://doi.org/10.1111/jnc.14663. (Q1, IF: 4.609)

Amalina Ahmad Azam, Intan Safinar Ismail, Mohd Farooq Shaikh, Khozirah Shaari and Faridah Abas. Effects of Clinacanthus nutans leaf extract on lipopolysaccharide -induced neuroinflammation in rats: A behavioral and 1H NMR-based metabolomics study. Avicenna Journal of Phytomedicine, 2019, 273, 9 (2), 164-186. DOI: 10.22038/AJP.2018.11787

2018 (Impact Factor: 23.28)

Alina Arulsamy, Yogini S Jaiswal, Bey Hing Goh, Saatheeyavaane Bhuvanendran, Thaarvena Retinasamy, Yatinesh Kumari, Iekhsan Othman, Leonard L Williams, Mohd. Farooq Shaikh. Neuroactive drugs–A perspective on drugs of synthetic and medicinal plants origin. Pharm Pharmacol Int J. 2018;6(6):422‒430.

Paudel, Y., Lisgaras, C., Lim, K. S. and Shaikh, M. F. “Epilepsy and Comorbidities: Towards unraveling the common underlying mechanisms”, Neuroscience Research Notes, 1(3), pp. 1-4. doi: 10.31117/neuroscirn.v1i3.20. (2018)

Yam N. Paudel, Mohd. Farooq Shaikh, Ángel Aledo Serrano, Yatinesh Kumari, Katina Aleksovska, Marina K. Alvim, Ayanabha Chakraborti, and Iekhsan B. Othman. HMGB1: A Common Biomarker and Potential Target for TBI, Neuroinflammation, Epilepsy and Cognitive Dysfunction. Frontiers in Neuroscience (2018). (Q1, 3.88)

Paudel, Y. N., Farooq Shaikh, M., Shah, S., Kumari, Y., Othman, I., Role of inflammation in epilepsy and neurobehavioral comorbidities: Implication for therapy. European Journal of Pharmacology (2018). (Q2, 3.01)

Muhammad Faiz Johan Arief, Brandon Kar Meng Choo, Jia Ling Yap, Yatinesh Kumari, Mohd Farooq Shaikh. A Systematic Review on Non-Mammalian Models in Epilepsy Research. Front. Pharmacol. doi: 10.3389/fphar.2018.00655 (2018). (Q1, IF: 4.4)

Saatheeyavaane Bhuvanendran, Yatinesh Kumari, Iekhsan Bin Othman, Mohd. Farooq Shaikh. Amelioration of cognitive deficit by embelin in a scopolamine-induced Alzheimer’s disease-like condition in a rat model. Front. Pharmacol. doi: 10.3389/fphar.2018.00665 (2018). (Q1, IF: 4.4)

Lin Lin Lee, V.; Kar Meng Choo, B.; Chung, Y.-S.; P. Kundap, U.; Kumari, Y.; Shaikh, M.F. Treatment, Therapy and Management of Metabolic Epilepsy: A Systematic Review. Int. J. Mol. Sci. 2018, 19, 871.. (2018). (Q2, IF: 3.2)

Choo BKM, Kundap UP, Kumari Y, Hue S-M, Othman I and Shaikh MF. Orthosiphon stamineus Leaf Extract Affects TNF-α and Seizures in a Zebrafish Model. Front. Pharmacol. 9:139. doi: 10.3389/fphar.2018.00139. (2018) (Q1, IF: 4.4)

Book /Book Chapters

Book Chapter: Choo B.K.M., Shaikh M.F. (2021) Methods to Investigate Seizures and Associated Cognitive Decline Using Zebrafish Model. In: Vohora D. (eds) Experimental and Translational Methods to Screen Drugs Effective Against Seizures and Epilepsy. Neuromethods, vol 167. Humana, New York, NY.

Book Chapter: Brandon Kar Meng Choo and Mohd. Farooq Shaikh (May 30th, 2018). Zebrafish Model of Cognitive Dysfunction, Recent Advances in Zebrafish Researches Yusuf Bozkurt, IntechOpen, DOI: null. Available from: https://www.intechopen.com/books/recent-advances-in-zebrafish-researches/zebrafish-model-of-cognitive-dysfunction

Book Chapter: Divya Suares, Mohd. Farooq Shaikh, Clara Fernandes (2018), Nanotechnological Approaches For Management Of NeuroAIDS. Apple Academic Press, Inc., USA. (In press).

Book Chapter: MF Shaikh, LL Williams (2018), Hypertension: Pharmacology of Antihypertensives. Recent Progress in Medicinal Plants: Metabolic disorders. Vol. 48. Studium Press LLC, Houston, USA. (In press).

Book Chapter: MF Shaikh, LL Williams (2018), Hyperlipidemia: Pharmacology of Antihyperlipidemics. Recent Progress in Medicinal Plants: Metabolic disorders. Vol. 47. Studium Press LLC, Houston, USA. (In press).

Abstracts

Mohd. Farooq Shaikh, Uday Kundap, Yatinesh Kumari. (2018). Pharmacological model development for chronic epilepsy-induced cognitive Dysfunction in zebrafish. Abstract book. 32nd Scientific Meeting of Malaysian Society of Pharmacology and Physiology, 2018, Hotel Bangi, Putrajaya, 8-9 August 2018.

Development of Chronic Model of Epilepsy induced Cognitive Dysfunction in Zebrafish (2018). Abstract Book. 17th Asian and Oceanian Myology Centre (AOMC) Annual Scientific Meeting & 28th Malaysian Society of Neurosciences (MSN) Annual Scientific Meeting, 2018, Hotel Istana, KL, 28-29 July 2018.

U P Kundap, Y Kumari, I Othman, M F Shaikh. (2017). Effect of embelin in chronic epilepsy induced cognitive dysfunction in three-axis maze model of adult zebrafish. Epilepsia, 58(Suppl. 5): S5–S199. DOI: 10.1111/epi.13944.

Uday P Kundap, Yatinesh Kumari, Iekhsan Othman, Mohd. Farooq Shaikh. Embelin, a potential molecule to ameliorate seizure induced cognitive decline in a T-maze zebrafish model. European Neuropsychopharmacology, 2016, 26, S273-S274. DOI: 10.1016/S0924-977X(16)31159-2.

Kundap UP, Bhuvanendran S, Kumari Y and Shaikh MF (2016). Development of a zebrafish model for epilepsy and antiepileptic drugs induced cognitive dysfunction. Front. Cell. Neurosci. Conference Abstract: 14th Meeting of the Asian-Pacific Society for Neurochemistry. doi: 10.3389/conf.fncel.2016.36.00169.

Bhuvanendran S, Kumari Y, Othman I and Shaikh MF (2016). Memory enhancing effect of embelin against scopolamine-induced amnesia in Sprague Dawley rats. Front. Cell. Neurosci. Conference Abstract: 14th Meeting of the Asian-Pacific Society for Neurochemistry. doi: 10.3389/conf.fncel.2016.36.00164.

Retinasamy T, Kumari Y, Othman I and Shaikh MF (2016). Orthosiphon stamineus improves disturbances of learning, recognition memory and spatial long-term memory in scopolamine-induced amnesia in rats. Front. Cell. Neurosci. Conference Abstract: 14th Meeting of the Asian-Pacific Society for Neurochemistry. doi: 10.3389/conf.fncel.2016.36.00189.

Mohd. Farooq Shaikh, Zurina Hassan, Yatinesh Kumari, Amin Malik Shah A M, Iekshan Othman. Orthosiphon Stamineus Improve Memory and Hippocampal Long-Term Potentiation Impairment in a Chronic Cerebral Hypoperfusion Model in Rat. Cerebrovascular Diseases 42(suppl 1):152 · July 2016. DOI: 10.1159/000447732.

Uday P Kundap, Yatinesh Kumari, Iekhsan Othman, Nafees Ahmed, Mohd. Farooq Shaikh. Embelin's affinity towards the GABAA receptor and the ability to modulate neurotransmitters makes it an anticonvulsant compound. 20th Thai Neurosciences Society International Conference, July 2016, at Naresuan University Phitsanulok, Thailand.

Mohd. Farooq Shaikh, Discovery of Anticonvulsants using Reverse Pharmacology: A Fast Track Pathway” is delivered at the 1st International Conference Of Pharmacy And Health Sciences 2016 18th – 20th March 2016, Hotel Casuarina, Meru, Ipoh, Malaysia.

Uday P Kundap, Tiang Ning, Yatinesh Kumari, Iekhsan Othman, Mohd. Farooq Shaikh. Cognitive Dysfunctioning By Epilepsy & AEDs In Zebrafish Model. Malaysia Zebrafish Disease Models held at Cancer Research Malaysia, SJMC, Malaysia, 11-12 Nov. 2015.

Tharveena Retinasamy, Saatheeyavaane Bhuvanendran, Mohd. Farooq Shaikh, Yatinesh Kumari, Iekshan Othman, Goh Bey Hing, Amin Malik Shah A M, Aman Shah A M, Zurina Hassan. The Effect of Ethanolic Orthosiphon stamineus Extract on Learning & Memory in Chronic Cerebral Hypoperfusion Induced Cognitive Impairment in Rats. CDR Mini-Symposium on Drug Addiction and Neurodegeneration held from the 4th - 6th November 2015 at Auditorium Ishak Pateh Akhir, Sains, USM, Bukit Jambul, Penang.

Saatheeyavaane Bhuvanendran, Tharveena Retinasamy, Mohd. Farooq Shaikh, Yatinesh Kumari, Iekshan Othman, Zurina Hassan. Pharmacological evaluation of phytocompound Embelin, derived from Embelia ribes in Alzheimer’s disease using chronic cerebral hypoperfusion rats. CDR Mini-Symposium on Drug Addiction and Neurodegeneration to be held from the 4th - 6th November 2015 at Auditorium Ishak Pateh Akhir, Sains, USM, Bukit Jambul, Penang.

MF Shaikh, Iekhsan Othman. Neuroproteomics: A Guiding Light for Neurodegenerative Diseases’ Therapy”. CDR Mini-Symposium on Drug Addiction and Neurodegeneration to be held from the 4th - 6th November 2015 at Auditorium Ishak Pateh Akhir, Sains, USM, Bukit Jambul, Penang.

Y Kumari, BH Goh, MF Shaikh. Piper betel,a novel melatonin agonist for the treatment of sleep disorder. International Conference on Biomedical & Health Sciences Research 2015, Putrajaya, Malaysia (25-27 January 2015).

Research Grants

JCSMHS Strategic Grant (2021-2022) entitled “Pathological Pathways of Acquired Epilepsy and their Comorbidities: A Translational Crosstalk between HMGB1 Mechanisms and Gut Microbiome”. (Role: Principal Investigator, RM 100,000)

FRGS (Fundamental Research Grant Scheme), Ministry of Higher Education, Malaysia (2020-2023), a project entitled “Embelin-Poloxamer conjugate as a synergistic combination for neurodegenerative diseases". (Principal Investigator, RM 132,000)

Monash Malaysia NEED Grant Scheme (2021 – 2023) “Development of Automated Epileptic Seizure Detection & Drug Based Prevention Device”. (Role: Principal Investigator, RM 262,000)

Monash Malaysia NEED Grant Scheme (2021 – 2023) “Malaysian Partners in Parenting (M-PiP): Adapting a Personalized Positive Parenting Digital Health Program for Youth Mental Health Promotion in Malaysia”. (Role: Co-Investigator, RM 333,500)

FRGS (Fundamental Research Grant Scheme), Ministry of Higher Education, Malaysia (2019-2021), a project entitled "Evaluation of Protective Mechanism of Embelin against Cyclophosphamide Induced Cardiotoxicity in Rats". (Role: Co-investigator, RM 177,500)

Malaysia NIH-IMR Research Grant (2021 – 2023) “Zebrafish As Alternative Model for Toxicity Profiling of Discorea hispida (Ubi Gadong)”. (Role: Co-investigator, RM 237,500)

Dana Fundamental PPUKM (2020-2022), the project entitled “Protein Analysis: Modulation of Basolateral Amygdala Mtorc-2-Pkc Pathway in Ethanol Withdrawal Induced Anxiety”. (Role: Co-Investigator, RM 10,000)

Star Goose Sdn Bhd-Industrial Grant entitled (2018 – 2020) "Evaluation of the anticonvulsant potential of Goose bone in an experimental model of epilepsy". (Role: Principal Investigator, RM 20,000)

FRGS (Fundamental Research Grant Scheme), Ministry of Higher Education, Malaysia (2016-2019), a project entitled "The role of the mGlu5-PKC epsilon-ERK1/2 molecular pathway in rat basolateral and central amygdalar glutamatergic hyperexcitability during ethanol withdrawal-induced anxiety". (Role: Co-investigator, RM 96,000)

eScience Research Fund, MOSTI (Ministry of Science, Technology and Innovation, Malaysia) (2014-2017), a project entitled “Embelin, a Malaysian plant-derived benzoquinone in the treatment of epilepsy-induced cognitive dysfunction”. (Role: Principal Investigator, RM 166,000)

NKEA Research Grant Scheme (NRGS) Ministry of Agriculture and Agro-Based Industry, Malaysia (2014 – 2017), the project entitled “Evaluations of neuroprotective activity of standardized ethanolic Orthosiphon stamineus extract ameliorate cognitive alterations in Alzheimer’s disease”. (Role: Co-investigator, RM 420,000)

NKEA Research Grant Scheme (NRGS) Ministry of Agriculture and Agro-Based Industry, Malaysia (2014 – 2017), the project entitled “Elucidating the anti-neuroinflammatory effect of Clinacanthus nutans on Lipopolysaccharide-induced neurotoxicity in BV2 cells and rat”. (Role: Co-investigator, RM 400,000)

Global Asia in the 21st Century (GA21) Large Grant (2021 – 2022) entitled “Autism and Sustainable Institutions: Barriers and Facilitators for Fostering Neurodiversity Inclusiveness and Wellbeing in Private-Sector Malaysian Workplaces in the Post-COVID World”. (Role: Co-investigator, RM 14,000)

JCSMHS Seed Grant 2020 “The timely alteration of TNF-α and TNFR1 expression and interaction affecting epileptogenesis in a post-traumatic epilepsy rodent model of mild diffuse TBI”. (Role: Co-investigator, RM 10,000)

School ECR Grant 2021 “The role of the gut microbiota in epilepsy associated depression using the C57BL/6 mouse model”. (Role: Co-investigator, RM 20,000)

School ECR Grant 2021 “Effect of Anakinra on Neuroinflammation in a Streptozotocin-induced Alzheimer’s Disease-Like Condition in a Rat Model”. (Role: Co-investigator, RM 20,000)

JCSMHS-BRIMS Collaborative Grant entitled (202 –2021) “Embelin-Poloxamer conjugate as a synergistic combination for neurodegenerative diseases". (Principal Investigator, RM 20,000)

Global Asia in the 21st Century (GA21) Large Grant (2020 – 2021) entitled “Stigmatized Diseases Through Religion: Misinformation, Trust, and Empowerment”. (Role: Co-Investigator, RM 20,000)

Tropical Biology and Medicine (TMB) Grant (2019), the project entitled "Therapeutic Potential of Curcumin Derivatives in Epileptic Seizures using Zebrafish as a Disease Model”. (Role: Principal Investigator, RM 8,000)

Global Asia in the 21st Century (GA21) Large Grant (2018 – 2020) entitled “National Key Economic Plant ‘Orthosiphon Stamineus’ Leaf for the Treatment of Epilepsy”. (Role: Principal Investigator, RM 25,350)

Global Asia in the 21st Century (GA21) Large Grant (2018 – 2020) entitled “Potent Neuroprotective Proteins Derived from Malayan Snake Venom in Alzheimer’s Disease”. (Role: Co-investigator, RM 29,310)

Global Asia in the 21st Century (GA21) Seed Grant (2018-2019) entitled “Investigation of the anticonvulsive effect of the venom from Malaysian pit vipers; Calloselasma rhodostoma (Malayan pit viper) and Cryptelytrops purpureomaculatus (Mangrove pit viper) using in-vivo zebrafish model”. (Role: Co-investigator, RM 10,000)

PVC Award 2018 for Excellence in Research – Early Career Category (2018 – 2019). Research Grant (Role: Principal Investigator, RM 20,000)

Tropical Biology and Medicine (TMB) Grant (2017 – 2018), the project entitled "Effect of Third Generation Anti-Epileptic Drugs (AEDs) On the Cognitive Status in An Epileptic Zebrafish Model”. (Role: Principal Investigator, RM 15,000)

ECR Seed Grant 2014, Monash University Malaysia, the project entitled “Evaluations of neuroprotective activity of standardized ethanolic Orthosiphon stamineus extract ameliorate cognitive alterations in Alzheimer’s disease”. (Role: Principal Investigator, RM 30,000)

Research Student Supervision

Post-doctoral supervision

  1. Dr Alina Arulsamy (March 2020 – present) – Research Fellow
  2. Dr Thaarrvena Retinasamy (April 2021 – present) – Research Fellow

Current

  1. Seyedeh Taher Mirani (Main Supervisor) - PhD

    Mechanism of the long noncoding RNA SNHG18 in downregulating Sema5A expression in human glioblastomas

  2. Vanessa Lin Lin Lee (Main Supervisor) - PhD

    Role of Malaysian Ikan Haruan (Channa striatus) Extract in Neuroinflammation-Mediated Epilepsy

  3. Brandon Choo Kar Meng (Main Supervisor) - PhD

    Effect of Newer Anti-Epileptic Drugs (AEDs) on the Cognitive Status in Pentylenetetrazol Induced Seizures in A Zebrafish Model

  4. Nurul Atiqah Zulazmi (Main Supervisor) – PhD

    Impact of Traumatic Brain Injury on epileptogenesis and neuropsychiatric disorders in a zebrafish model

  5. Irma Wati (Main Supervisor) – PhD

    Role of HMGB1 in post-traumatic epilepsy and related cognitive dysfunction in TBI patients

  6. Hadri Hadi Yusof (Main Supervisor) – PhD

    Embelin-Poloxamer conjugate as a synergistic combination for neurodegenerative diseases

  7. Atiqah Haizum Abdullah (Co-Supervisor) - PhD

    Discovery of Biological Active Molecule from Malayan Snake Venom for Neurodegenerative Disease

  8. Hui Xian Fong (Co-Supervisor) - PhD

    Executive Functioning Among Children with Autism Spectrum Disorder in Malaysia: A Developmental Perspective

  9. Tugba Buday (Co-Supervisor) - PhD

    Sleep and Wellbeing in Malaysian Families of Primary and Secondary School-Age Children with Autism Spectrum Disorder: A Longitudinal Perspective

  10. Shantini a/p Vijayabalan (Taylor’s University) (External Co-Supervisor) - PhD

    Effects of Curcumin and Piperine on the Degeneration of Β-amyloid Proteins In Streptozotocin-induced Alzheimer Disease-like Condition In Sprague Dawley Rats

  11. Phuna Zhi Xin (Taylor’s University) (External Co-Supervisor) – PhD

    Dysbiosis in Alzheimer’s Disease like model using smart nanocrystals of curcumin and piperine.

  12. Maha Shahid (University of Karachi) (International Co-Supervisor) - PhD

    Modulating neurogenesis to target ischemic stroke by using analogs of salicylates

  13. Muhammad Azam (University of Karachi) (International Co-Supervisor) - PhD

    RGMa-FAK-Ras pathway in hippocampal mossy fiber sprouting in the pentylenetetrazole kindling model and its modulation by novel antiepileptic compounds

  14. Haziq Aiman (UKM) (External Co-Supervisor) - Master

    Involvement of Mammalian Target of Rapamycin Complex 2 (Mtorc2) And Protein Kinase C Epsilon (Pkcε) In Ethanol Withdrawal-induced Anxiety

  15. Siti Nurul Najiha Othman (UniKL) (External Co-Supervisor) - Master

    Evaluation of Protective Mechanism of Embelin against Cyclophosphamide induced Cardiotoxicity in Rats.

  16. Lum Pei Teng (UniKL) (External Co-Supervisor) - PhD

    Neuroprotective Effect of Mangiferin against 3-Nitropropionic Acid-Induced Huntington’s disease in Rats.

  17. Rayan Sayedgotb Mustafa Elrashied (Sunway University) (External Co-Supervisor) – Master
  18. Medicinal Plants-based Natural Products as Potential Antiamoebic Agents: A transcriptomic approach

Completed

  1. Yam Nath Paudel (Main Supervisor) – PhD (2021)

    Investigation of the plausible role of HMGB1 in chronic epilepsy-related cognitive dysfunction in zebrafish

  2. Chung Yin-Sir Alexis (Main Supervisor) – PhD (2020)

    Investigation on Orthosiphon stamineus Benth Proteins in Central Nervous System

  3. Uday P. Kundap (Main Supervisor) – PhD (2019)

    Pharmacological Evaluation of Embelin in Epilepsy Induced Cognitive Impairment in Zebrafish

  4. B. Saatheeyavaane Pillai (Main Supervisor) – PhD (2019)

    Neuroprotective Effect of Embelin in Experimental Models of Alzheimer's Disease

  5. Thaarvena Retinasamy (Main Supervisor) – PhD (2019)

    Evaluation of Neuroprotective Activity of Standardized Ethanolic Orthosiphon stamineus Extract to Ameliorate Cognitive Alterations in Alzheimer's Disease

  6. Atif Usman (Co-Supervisor) – PhD (2021)

    Cardiovascular Complications in Diabetic Ketoacidosis: Clinical and Experimental Approach for Improved Diagnosis and Management

  7. Farah Rehan (Co-Supervisor) – PhD (2021)

    Cardiovascular Complications in Diabetic Ketoacidosis: Clinical and Experimental Approach for Improved Diagnosis and Management

  8. Mohammad Borhan Uddin (Co-Supervisor) – PhD (2020)

    Evaluation of inorganic nanocrystals as potential tools for delivery of siRNA targeting ion channels and transporters in breast cancer cells

  9. Amalina Azam (UPM) (External Co-Supervisor) – PhD (2019)

    Elucidating the anti-neuroinflammatory effect of Clinacanthus nutans on Lipopolysaccharide (LPS)-induced neurotoxicity in BV2 cells and rats.

  10. Qian Ying Tan (Main Supervisor) – B. Med. Sci. (Honours) (2019)

    Impact of Epilepsy on Gut Microbiota and Possible Therapeutics

  11. Hsien Lee -Nicholas (Co-Supervisor) – B. Sci. (Honours) (2020)

    Evaluating the antiepileptic potential of chalcones in a zebrafish model

  12. Jingwen Lynn Tan (Co-Supervisor) – B. Psych. Sci. (Honours) (2020)

    Sleep Problems and Their Association With Inattention and Hyperactivity-Impulsivity Symptoms Among Malaysian Children With Autism Spectrum Disorder

  13. Ong Xin Lin (Co-Supervisor) – B. Psych. Sci. (Honours) (2020)

    Sleep and Externalizing Behaviours in Malaysian Children with Autism Spectrum Disorder: The Mediating Role of Executive Function

  14. Yiew Jin (Co-Supervisor) – B. Sci. (Honours) (2019)

    Snake venom protein as a therapeutic strategy for epilepsy and memory

  15. Sabrina Ooi Xu Peng (Co-Supervisor) – B. Sci. (Honours) (2019)

    Impact of Sleep Deprivation on Neurobehavioral Parameters in a Zebrafish Model

  16. Yanning Yong (Co-Supervisor) – B. Sci. (Honours) (2019)

    Cell-based and zebrafish (Danio rerio) phenotypic investigation of cytotoxic properties in Arctium lappa L. root extract

  17. Qi En Goh (Co-Supervisor) – PGDip. BioMed Sci. (2018)

    The Identification and Partial Purification of Acetylcholinesterase (Ache) in Naja sumatrana and Ophiophagus hannah Venom

  18. Brandon Choo Kar Meng (Co-Supervisor) – B. Sci. (Honours) (2017)

    Evaluation of the anticonvulsant potential of Orthosiphon stamineus in zebrafish

  19. Jing Ying (Co-Supervisor) – B. Sci. (Honours) (2015)

    Effect of medicinal plant in an experimental model of infertility

  20. Alina Arulsamy (Co-Supervisor) – B. Sci. (Honours) (2014)
  21. Pharmacological Evaluation of Leucaena leucocephala in Anxiety and Depression

Awards and Fellowships

  • JCSMHS 2019 Best Publication Award for the paper entitled “Effect of newer anti-epileptic drugs (AEDs) on the cognitive status in pentylenetetrazol induced seizures in a zebrafish model”. Prog Neuropsychopharmacol Biol Psychiatry. 2019 Mar 4;92:483-493. doi: 10.1016/j.pnpbp.2019.02.014 (Q1, IF: 4.185).
  • “Young Researcher Award 2019” by Malaysian Society of Pharmacology and Physiology (MSPP), during 33rd Annual Meeting of MSPP at Everly Hotel, Putrajaya, Malaysia on 15-16 July 2019.*
  • “Young Teachers Award 2019” for Pharmacology category by Malaysian Society of Pharmacology and Physiology (MSPP), during 33rd Annual Meeting of MSPP at Everly Hotel, Putrajaya, Malaysia on 15-16 July 2019.
  • Pro-Vice Chancellor’s (PVC) Award 2018 for Excellence in Research – Early Career Category by Monash University Malaysia
  • Malaysian Society of Neurosciences (MSN) 2018 Best Publication Award for the paper entitled “Zebrafish as a Model for Epilepsy-Induced Cognitive Dysfunction: A Pharmacological, Biochemical and Behavioral Approach”.
  • Best Poster Award at Monash Medicine Curriculum Conference 2018 for the project “Innovative Approach to Enhance Medical Students’ Learning of Basic Immunology Concepts”.
  • Silver Medal at ITEX 2018
  • Bronze Medal at PECIPTA 2017
  • IBRO-APRC Exchange Fellowship-2012, to work at the University of Queensland, Brisbane, Australia (Only 3 scientists from Asia-pacific region are selected every year by the International Brain Research Organization (IBRO) for this prestigious program). (Role: Visiting Academic, USD 8500)
  • Fellow-Young Investigator Program (YIP) -2011, selected by the International Brain Research Organization (IBRO) to undergo training in the European laboratory-Milano, Italy, 2011. (Only 75 scientists from laboratories all over the world were selected for this prestigious program).
  • International Brain Research Organization (IBRO) Travel Fellowship to participate and present a paper at 8th World Congress of Neuroscience, Florence, 2011.
  • Senior Research Fellowship, Indian Council of Medical Research, India, 2010.
  • Senior Research Fellowship, University Grants Commission- MANF, India 2009.
  • Research Scholarship, Dr. Palep’s Medical Research Foundation, India, 2008.

Innovation and Patents

  • Participated and won a SILVER medal at annual ITEX 2018, an exhibition aimed to cultivate the ability to think critically - a quality separating innovators from followers, for the project entitled “Lanctos 75TM for Mental Wellness”.
  • Participated and won a BRONZE medal at PECIPTA 2017, an International Conference and Exposition on Inventions by Institutions of Higher Learning, Malaysia, for the project entitled “NP-A as A Memory Enhancer and Potential Molecule for Neurodegenerative Diseases”.
  • A patent entitled "A Pharmaceutical Composition for Treating a Sexual Dysfunction in Males and a Method for Producing Thereof" has been filed before Malaysia Intellectual Property Office (MyIPO). The details of the said patent application are as follows:
    Application No.     : PI 2017702515
    Applicant: Monash University Malaysia
    Filing Date: 10 July 2017
  • A patent entitled “Extract Of Orthosiphon Stamineus, Formulations, And Uses Thereof” will be filed by the end of Aug 2017 with industry partner Natureceuticals.

Professional Memberships

  • Regional Representative- Young Epilepsy Section-International League Against Epilepsy (YES-ILAE)
  • Member – International Brain Research Organization (IBRO)
  • Life Member – Malaysian Society of Neuroscience (MSN)
  • Ex-co and Life Member – Malaysian Society of Epilepsy
  • Member – Malaysian Society of Pharmacology & Physiology (MSPP)
  • International Member – American Epilepsy Society (AES)
  • Member – MONASH University Institute of Graduate Research (Level 2)
  • Member – ADI-Advisors, ADI Instruments Ltd.
  • Member- Registered Pharmacist, Maharashtra State Pharmacy Council (MSPC)
  • Topic Editor: Frontiers in Pharmacology, Frontiers in Neurology and Frontiers in Neuroscience
  • Topic Editor: Neuroscience Research Notes
  • Editorial Board Member: International Journal of Pharmacy and Pharmaceutical Sciences (IJPPS),  International Journal of Advances in Pharmacy, Medicine and Bioallied Sciences (Int J Adv Pharm MED Bioallied Sci), Pharmacy & Pharmacology International Journal, Research in Pharmacy and Health Sciences
  • Reviewer :
    • Neurobiology of Disease
    • Journal of Neurochemistry
    • ACS Chemical Neuroscience
    • Neuropharmacology
    • Frontiers in Pharmacology
    • ACS Molecular Pharmaceutics
    • Brain Sciences
    • Experimental Biology and Medicine
    • Journal of Neuroimmune Pharmacology
    • Journal of Psychiatric Research
    • Journal of Neuroinflammation
    • Phytotherapy Research
    • BMC Complementary and Alternative Medicine
    • International Journal of Molecular Sciences, mdpi
    • European Journal of Pharmaceutical Sciences
    • Biomedicine & Pharmacotherapy
    • Nutrients
    • Life Sciences
    • Brazilian Journal of Pharmaceutical Sciences
    • Journal of Medicinal Plant Research
    • Current Science
    • International Journal of Pharmacy and Pharmaceutical Sciences
    • Indian Journal of Pharmaceutical Education and Research

Academic visits

  • Visiting Researcher, Department of Neuroscience, Central Clinicla School, The Alfred Hospital, Monash University, Melbourne, Australia. Feb. 2019 to June 2019.
  • Institute of Neurology, University College London,  London, UK, on  14th May 2018.
  • Research Centre for Neurosciences Mahidol University, Bangkok, Thailand. Basic Neuroscience Chapter- Malaysian Society of Neuroscience, Delegates’ visit, 19-21 November 2017.
  • Institute of Neurological Sciences Venice, Summer School Program at Venice International University, San Servolo, Venice; 16-29 July 2017.